Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Published:2017-07-11 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Ahmad Hamdi Abdul Hafeez,Dali Ahmad Fauzi,Mat Nuri Thimarul Huda,Saleh Muhammad Syafiq,Ajmi Noor Nabila,Neoh Chin Fen,Ming Long Chiau,Abdullah Amir Heberd,Khan Tahir Mehmood

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-st-segment elevation acute coronary syndromes patients: an analysis from the early glycoprotein iib/iiia inhibition in non-st-segment elevation acute coronary syndrome trial;Bagai;Am. Heart J.,2013

2. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or post-infarction angina;Bittl;N. Engl. J. Med.,1995

3. Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials;Cassese;EuroIntervention,2015

4. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials;Cavender;Lancet,2014

5. Bivalirudin in contemporary percutaneous coronary intervention for non-st-segment elevation acute coronary syndromes: what is the current role of platelet glycoprotein iib/iiia receptor inhibitor agents?;Centurion;Crit. Pathw. Cardiol.,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Catheterization and Coronary Arteriography;Ischemic Heart Disease;2023

2. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02

3. Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study;Frontiers in Cardiovascular Medicine;2022-06-16

4. Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study;Frontiers in Cardiovascular Medicine;2022-04-29

5. The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2022-04-14